|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Judge Denies Delay in Pfizer Inc. (PFE) Chantix Trial
10/17/2012 8:36:29 AM
A federal judge in Alabama late Tuesday afternoon denied a request by Pfizer Inc. to delay by three months next week's start of a federal trial in a lawsuit that claims the pharmaceutical giant's anti-smoking drug Chantix caused a Minnesota man to commit suicide. "Given the current posture of this case, the court is of the opinion that a three-month continuance is not appropriate or needed," U.S. District Judge Inge Johnson wrote in her ruling. Judge's ruling: Pfizer made the request to delay the trial after the release today of a new clinical study on Chantix. Pfizer's motion seeking delay: The trial, which is to begin Monday in Florence, Ala., is set to be the first federal lawsuit to go before a jury out of more than 2,600 lawsuits filed so far against Pfizer over Chantix. The lawsuits, filed by smokers or their families, claim the drug has caused suicides, suicide attempts, or other psychological problems.
|
|
|
|
|
|
|
|
|
|
|